Progesterone Timing in the Menstrual Cycle
For luteal phase support in hormone replacement therapy or premature ovarian insufficiency, progesterone should be taken for 12-14 consecutive days every 28 days when using sequential regimens, or continuously when using continuous combined regimens. 1
Context-Specific Recommendations
For Hormone Replacement Therapy (Sequential Regimen)
When estrogen is administered continuously (transdermal or oral), add progesterone for 12-14 days out of every 28-day cycle 1:
- Oral/vaginal micronized progesterone: 200 mg daily for 12-14 days per month
- Medroxyprogesterone acetate (MPA): 10 mg daily for 12-14 days per month
- Dydrogesterone: 10 mg daily for 12-14 days per month
This sequential approach induces withdrawal bleeding and provides endometrial protection while mimicking a more natural hormonal pattern.
For Continuous Combined Regimens (Avoiding Withdrawal Bleeding)
Progesterone is taken every single day without interruption 1:
- Oral norethisterone: minimum 1 mg daily continuously
- Oral MPA: minimum 2.5 mg daily continuously
- Oral dydrogesterone: minimum 5 mg daily continuously
For Prevention of Endometrial Hyperplasia in Postmenopausal Women
The FDA-approved regimen is 200 mg progesterone capsules taken at bedtime for 12 continuous days per 28-day cycle when combined with estrogen therapy 2. This timing was validated in clinical trials showing a 64% reduction in endometrial hyperplasia compared to estrogen alone (6% vs 64% hyperplasia rate).
For Secondary Amenorrhea (Inducing Withdrawal Bleeding)
Progesterone 400 mg is taken at bedtime for 10 consecutive days 2. In clinical trials, this resulted in 80% of women experiencing withdrawal bleeding within 7 days of the last dose.
For Frozen Embryo Transfer (Luteal Phase Support)
The timing depends on cycle type 3:
- Natural or ovarian stimulation cycles: Begin progesterone supplementation after ovulation or after luteinization
- Artificial cycles: Begin progesterone on the day of endometrial transformation
- Continue for 1-3 weeks after pregnancy confirmation in natural cycles, or 3-4 weeks in artificial cycles with gradual dose reduction over 2 weeks
Important Clinical Considerations
Micronized progesterone (MP) is the preferred progestin due to lower cardiovascular and thrombotic risks compared to synthetic progestins 1. This is particularly important in populations at higher baseline cardiovascular risk.
Timing of administration matters for tolerability: Progesterone capsules should be taken at bedtime because some women experience extreme dizziness, drowsiness, blurred vision, or difficulty walking during initial therapy 2. Taking medication at bedtime while standing with a glass of water minimizes these symptoms.
Common Pitfall to Avoid
Do not confuse sequential hormone replacement regimens with contraceptive pill packs. In HRT, progesterone is only needed for 12-14 days per month to protect the endometrium, not continuously throughout the cycle like in birth control pills. The remaining days of the cycle use estrogen alone.
Duration of Therapy
For women with premature ovarian insufficiency, continue hormone replacement therapy until the average age of natural menopause (45-55 years) 1. Stopping earlier increases risks of osteoporosis, cardiovascular disease, and other complications of estrogen deficiency.